DAPK1 and ovarian cancer: In addition, sequential treatment with gliotoxin followed by paclitaxel activated the DAPK1-mediated TAp63 signaling pathway to induce autophagic cell death in paclitaxel-resistant ovarian cancer cells (Figure 6).